The heart and antiphospholipid antibodies. Personal experience and review;COEUR ET ANTICORPS ANTIPHOSPHOLIPIDES. EXPERIENCE PERSONNELLE ET REVUE DE LA LITTERATURE

Revue de Medecine Interne

Volumn 17, Issue 1, 1996, Pages 46-57

  Laraki, R ^a,b   Bletry O ^b   Wechsler, B ^a,b   Piette, J C ^a,b   De Zuttere, D ^a,b   Godeau, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

anticardiolipin; antiphospholipids; autonomic neuropathy; cardiomyopathy; heart; myocardial infarction; rheumatic fever; stroke; thrombosis; valvular heart disease

Indexed keywords

BETA2 GLYCOPROTEIN; CARDIOLIPIN ANTIBODY; UNCLASSIFIED DRUG; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; AUTONOMIC NEUROPATHY; HEART INFARCTION; HUMAN; PATHOGENESIS; PROGNOSIS; REVIEW; RHEUMATIC FEVER; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VALVULAR HEART DISEASE; HEART DISEASE; IMMUNOLOGY; PHYSIOLOGY;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; HEART DISEASES; HUMANS; PROGNOSIS;

EID: 0030040401     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)88395-0     Document Type: Article

References (78)

1. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987;26:324-26
2. Laraki R, Blétry O, Piette JC, Godeau P. Le syndrome des antiphospholipides. Sang Thrombose Vaisseaux 1991;6:363-9
3. Kaplan SD, Chartash EK, Pizzarello RA, Furie RA. Cardiac manifestations of the antiphospholipid syndrome. Am Heart J 1992;124:1331-8
4. Nihoyannapoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 1990;82:369-75
5. Leung WH, Wong KL, Lau CP et al. Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 1990;89:411-9
6. Laraki R, Blétry O, Godeau P. Les péricardites lupiques. Ann Méd Interne 1992;143:233-7
7. Baker WF, Bick RL. Antiphospholipid antibodies in coronary artery disease: a review. Semin Thromb Hemostasis 1994;20:27-45
8. Mandell BF. Cardiovascular involvement in SLE. Semin Arthritis Rheum 1987;17:126-41
9. Badui E, Garcia-Rubi D, Robles E et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985;36:431-41
10. Lanore JJ, Piette JC, Chapelon C et al. Infarctus du myocarde au cours du lupus érythémateux systémique. Sept observations chez six malades. Ann Méd Interne 1990;141:519-25
11. Jonsson H, Nived O, Strufelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine 1989;68:141-50
12. Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976;60:221-5
13. Petri M, Lakatta C, Magler L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994;96:254-9
14. Asherson RA, Khamashta MA, Baguley E, Oakley CM, Rowell NR, Hughes GRV. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med 1989;73:1103-15
15. Brown JH, Doherty CC, Allen DC, Morton P. Fatal cardiac failure due to myocardial micro-thrombi in systemic lupus erythemtosus. Br Med J 1988;296:1505
16. Greisman SG, Thayaparan RS, Godwin TA, Lockshin MD. Occlusive vasculopathy in systemic lupus erythematosus. Association with anticardiolipin antibody. Arch Intern Med 1991;151:389-92
17. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-8
18. Asherson RA, Khamashta MA, Ordi-Ros J et al. The "primary" antiphospholipid syndrome: a major clinical and serological features. Medicine 1989;68:366-74
19. Murphy JJ, Learch IH. Findings at necropsy in the heart of a patient with antiphospholipid syndrome. Br Heart J 1989;62:61-4
20. Kattwinkel N, Villanueva AG, Labib SB et al. Myocardial infaction caused by cardiac microvasculopathy in a patient with primary antiphospholipid syndrome. Ann Intern Med 1992;116:974-6
21. Thorp JM, Chescheir NC, Fann B. Post-partum myocardial infarction in a patient with antiphospholipid syndrome. Am J Perinatol 1994;11:1-3
22. Dacosta A, Norberg R, Björkholm U, De Faire U, Holm G. Infarctus indolore au cours du syndrome des antiphospholipides. Arch Mal Cœur 1993;86:1773-5
23. Khamashta MA, Cuadrado MJ, Mujic F et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7
24. Hamsten A, Norberg R, Björkholm U, De Faire U, Holm G. Antibodies to anticardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet 1986;i:113-6
25. Phadke KV, Phillips Ra, Clarke DTR et al. Anticardiolipin antibodies in ischemic heart disease: marker or myth? Br Heart J 1993;69:391-4
26. Edwards T, Thomas RD, Mettugh NJ. Anticardiolipin antibodies in ischaemic heart disease. Lancet 1993;342:689
27. Asherson RA, Cervera R. Antiphospholipid antibodies and the heart (reply). Circulation 1992;85:2332
28. Vaarala O, Mänttari M, Manninen V et al. Anticardiolipin antibodies and risk of myocardial infarction in prospective cohort of middle-aged men. Circulation 1995;91:23-7
29. Sletnes KE, Smith P, Abdelnoor M, Arnesen H, Wisloff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-hemorrhagic stroke. Lancet 1992;339:451-3
30. Raghavan C, Ditchfield J, Taylor RJ, Haeney MR, Barnes PC. Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction. J Clin Pathol 1993;46:1113-5
31. Eber B, Kronberger-Schaffer E, Brussee H et al. Anticardiolipin antibodies: no marker for survived myocardial infarction. Klin Wochenschr 1990;68:594-6
32. Cortellaro M, Boschetti C, Cardillo M, Barbui T. Antiphospholipid antibodies in patients with previous myocardial infarction. Lancet 1992;339:928-30
33. Yilmaz E, Adalet K, Yilmaz G et al. Importance of serum anticardiolipin antibody levels in coronary heart disease. Clin Cardiol 1994;11:117-21
34. Mattila K, Vaarala O, Palosvo T et al. Serologic response against cardiolipin and enterobacterial common antigen in young patients with acute myocardial infarction. Clin Immunol Immunopathol 1989;51:414-8
35. Webber SA, Wilson NJ, Fung MY. Auto-antibody production after cardiopulmonary bypass with special reference to post-pericardiotomy syndrome. J Pediatr 1992;121:744-7
36. Morton KE, Gavaghan TP, Krilis SA et al. Coronary artery bypass graft failure - an autoimmune phenomenon? Lancet 1986;ii:1353-6
37. Gavaghan TP, Krilis SA, Daggard GE et al. Anticardiolipin antibodies and occlusion of coronary artery bypass grafts. Lancet 1987;ii:977-8
38. Karmochkine M, Piette JC, Mazoyer E et al. Anticorps antiphospholipides:cause des thromboses ou épiphénomène ? Presse Méd 1995;24:267-70
39. Piette JC, Le Thi Huong Du, Laraki R et al. Les valvulopathies des connectivites. Ann Méd Interne 1992;143:251
40. Galve E, Candell-Rieva J, Pigraw C et al. Prevalence, morphologic types, and evolution of cardiac vascular disease in systemic lupus erythematosus. N Engl J Med 1988;319:817-23
41. D'Alton JG, Preston DN, Bormanis J et al. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 1985;16:512-4
42. Chartash EK, Lans DM, Paget SA et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and antiphospholipid syndrome. Am J Med 1989;86:407-12
43. Khamashta MA, Cervera R, Asherson RA et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541-4
44. Cervera R, Font J, Paré C et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992;51:156-9
45. Durieu I, Piette JC, Blétry O et al. Favourable results of heart valve surgery in systemic lupus erythematosus and primary antiphospholipid syndrome. Report of 9 cases. Lupus 1995;4 (Suppl 2):124
46. Asherson RA, Gibson DG, Evans DN et al. Diagnostic and therapeutic problems in two patients with transient attacks. Ann Rheum Dis 1988;47:947-53
47. Ford PM, Ford SE, Lillicrap DP. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol 1988;15:597-600
48. Brenner B, Blumenfeld Z, MArkiewicz W, Reisner SA. Cardiac involvement in patients with primary antiphospholipid syndrome. J Am Coll Cardiol 1991;18:931-6
49. Galve E, Ordi J, Barquinero J et al. Valvular heart disease in the primary antphospholipid syndrome. Ann Intern Med 1992;116:293-8
50. Vianna JL, Khamashta MA, Ordi-Ros J et al. Comparison of the primary and secondary antiphospholipid syndrome: A european multicenter study of 114 patients. Am J Med 1994;96:3-9
51. Cervera R, Khalmashta MA, Font J et al. High prevalence of significant valve lesions in patients with "primary" antiphospholipid syndrome. Lupus 1991;1:43-7
52. Hachulla E, Bataille D, Janin A et al. Double remplacement valvulaire révélateur d'un syndrome des antiphospholipides. Rev Méd Interne 1992;13:221-4
53. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteriod therapy: a study of 36 necropsy patients. Am J Med 1975;58:243-64
54. Laraki R, Blétry O, Horellou MH et al. Corrélations entre anticorps antiphospholipides et lésions neurologiques centrales ou cardiaques. Rev Méd Interne 1990;11:S285
55. Amigo MC, Garcia-Torres R, de la Rosa A, Reyes A. Histopathologic characterization of valvular damage in the primary antiphospholipid syndrome [Abstract]. Arthritis Rheum 1994;37:S176
56. Nickele GA, Foster PA, Kenny D. Primary antiphospholipid syndrome and mitral valve thrombosis. Am Heart J 1994;128:1245-7
57. Ziporen L, Goldberg I, Asherson R et al. The pathogenisis of valve involvement in antiphospholipid syndrome [Abstract]. Lupus 1994;3:315
58. Ford SE, Charrette EJP, Knight J et al. A possible role for antiphospholipid antibodies in acquired cardiac valve deformity. J Rheumatol 1990;17:1499-1503
59. Towheed TE, Ford PM, Pym JH, Ford SE. Cardiac valve replacement: a five year follow-up [Abstract]. Lupus 1994;3:322
60. Colorio C, Forasterio R, Mazzolenis D, Carreras LO. Anticardiolipin andibodies in heart valve disease [Abstract]. Lupus 1994;3:321
61. Barbut D, Borer JS, Gharavi A et al. Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events. Am J Cardiol 1992;70:901-5
62. Figueroa F, Berrios X, Gutierrez M et al. Anticardiolipin antibodies in acute rheumatic fever. J Rheumatol 1992;19:1175-80
63. Figueroa F, Berrios X, Gutierrez M et al. Antiphospholipid antibodies in rheumatic fever chorea (Reply). J Rheumatol 1994;21:1368
64. Diniz REAS, Goldenberg J, Andrade LEC et al. Antiphospholipid antibodies in rheumatic fever chorea. J Rheumatol 1994;21:1367
65. Barbut D, Borer JS, Wallerson D et al. Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events. Cardiology 1991;79:99-109
66. Nardone Soscia PN, Romain PL. Antiphospholipid antibodies: is there a role in cardiac valvular diseases and its thromboembolic complications? Cardiology 1992;80:1-6
67. Hachulla E, Leys D, Deleume JF et al. Manifestations neurologiques associées aux anticorps antiphospholipides ou que reste-t-il du neurolupus ? Rev Méd Interne 1995;16:121-30
68. Leventhal LJ, Borofsky MA, Bergey PD et al. Antiphospholipid antibody syndrome with right atrial thrombosis mimicking an atrial myxoma. Am J Med 1989;87:111-3
69. Lubbe WF, Asherson RA. Intracardiac thrombus in systemic lupus erythematosus associated with lupus anticoagulant. Arthritis Rheum 1988;31:1453-4
70. Coppock MA, Safford RE, Danielson GK. Intracardiac thrombosis, phospholipid antibodies, and two-chambered right ventricle. Br Heart J 1988;60:455-8
71. Combe H, Bauduceau B, Meyer L et al. Anticorps antiphospholipide associé à un myxome cardiaque simulant une connectivite. Presse Méd 1994;22:1059
72. Kochenour NK, Branch DW, Rote NS, Scott JR. A new postpartum syndrome associated with antiphospholipid antibodies. Obstet Gynecol 1987;69:460-8
73. Metz D, Jolly D, Graciet-Richard J et al. Anomalies cardiaques dans le lupus érythémateux disséminé diagnostiquées par échographie doppler. Prévalence et association au syndrome des antiphospholipides. Presse Méd 1994;23:1797-802
74. Coudray N, De Zuttere D, Blétry O et al. Altération de la fonction ventriculaire gauche diastolique au cours du syndrome primitif des anticorps antiphospholipides. Rev Méd Interne 1993;14:938
75. Hoyle C, Ewing DJ, Parker AC. Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis 1985;44:420-4
76. Louzir B, Laraki R, Blétry O, Braz De Lima JB, Bouche P, Godeau P. Hypotension orthostatique révèlant un lupus systémique. Rev Méd Interne 1992;7(Suppl):S421
77. Magaro M, Mirone L, Altomonte L et al. Lack of correlation between anticardiolipin antibodies and autonomic nerve involvement in systemic lupus erythematosus. Clin Rheumatol 1992;11:231-4
78. Lioté F, Osterland CK. Autonomic neuropathy in systemic lupus erythematosus: cardiovascular function assessment. Ann Rheum Dis 1994;53:671-4